Exhaustion in name only: CD8+ T cells drive lupus nephritis
Immunity · 2026-06 · 59 (6) · 1484-1486
DOI: 10.1016/j.immuni.2026.05.008 ↗Kurz gefasst
Kommentar in der Zeitschrift Immunity, 2026-06. Verfasst von Guillem Montamat-Garcia und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunity and Transplantation, Division of Infection and Immunity, Royal Free Hospital, University College London, London NW3 2PP, UK. Hauptthemen laut MEDLINE: Lupus Nephritis, CD8-Positive T-Lymphocytes. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Systemic lupus erythematosus is characterized by autoantibodies against nuclear antigens. In this issue of Immunity, Al Souz et al. report that kidney damage in lupus nephritis is sustained by stem-like CD8+ T cells that migrate from lymphoid tissues and then, driven by CD4+ T cells and IL-15 and IL-21, differentiate into cytotoxic effectors within tissue and retain pathogenic function despite exhaustion markers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Immunity and Transplantation, Division of Infection and Immunity, Royal Free Hospital, University College London, London NW3 2PP, UK.
- Institute of Immunity and Transplantation, Division of Infection and Immunity, Royal Free Hospital, University College London, London NW3 2PP, UK. Electronic address: c.mauri@ucl.ac.uk.
Zitieren
APA
Montamat-Garcia, G., & Mauri, C. (2026). Exhaustion in name only: CD8+ T cells drive lupus nephritis. Immunity, 59(6), 1484-1486. https://doi.org/10.1016/j.immuni.2026.05.008
Vancouver
Montamat-Garcia G, Mauri C. Exhaustion in name only: CD8+ T cells drive lupus nephritis. Immunity. 2026;59(6):1484-1486. doi:10.1016/j.immuni.2026.05.008
BibTeX
@article{MontamatGarcia2026,
author = {Montamat-Garcia, Guillem and Mauri, Claudia},
title = {Exhaustion in name only: CD8+ T cells drive lupus nephritis},
journal = {Immunity},
year = {2026},
volume = {59},
number = {6},
pages = {1484--1486},
doi = {10.1016/j.immuni.2026.05.008}
}
EUVIMED